9997 — Kangji Medical Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual income statement for Kangji Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	511	690	786	926	1,009
Cost of Revenue
Gross Profit	431	563	635	741	798
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	201	156	221	335	301
Operating Profit	310	535	565	591	707
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	310	534	563	589	685
Provision for Income Taxes
Net Income After Taxes	259	457	461	452	571
Minority Interest
Net Income Before Extraordinary Items
Net Income	250	457	479	504	581
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	250	457	479	504	581
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.288	0.371	0.396	0.43	0.495
Dividends per Share